Research output per year
Research output per year
Research output
Search results
-
2021
Acetyl-CoA Synthetase 2: A Critical Linkage in Obesity-Induced Tumorigenesis in Myeloma
Li, Z., Liu, H., He, J., Wang, Z., Yin, Z., You, G., Wang, Z., Davis, R. E., Lin, P., Bergsagel, P. L., Manasanch, E. E., Wong, S. T. C., Esnaola, N. F., Chang, J. C., Orlowski, R. Z., Yi, Q. & Yang, J., Jan 5 2021, In: Cell Metabolism. 33, 1, p. 78-93.e7Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
Analysis of the Implementation of Telehealth Visits for Care of Patients With Cancer in Houston During the COVID-19 Pandemic
Darcourt, J. G., Aparicio, K., Dorsey, P. M., Ensor, J. E., Zsigmond, E. M., Wong, S. T., Ezeana, C. F., Puppala, M., Heyne, K. E., Geyer, C. E., Phillips, R. A., Schwartz, R. L. & Chang, J. C., Jan 1 2021, In: JCO oncology practice. 17, 1, p. e36-e43Research output: Contribution to journal › Article › peer-review
Open Access11 Scopus citations -
ANETT: PhAse II trial of NEoadjuvant TAK-228 plus Tamoxifen in patients with hormone receptor-positive breast cancer
Koca, E., Niravath, P. A., Ensor, J., Patel, T. A., Li, X., Hemati, P., Wong, H., Qian, W., Boone, T., Zhao, J., Ramshesh, P. V., Cohen, A. L., Murthy, A., Nair, S., Darcourt, J. G., Belcheva, A., Kaklamani, V. G. & Chang, J. C. N., Jul 2021, In: Breast Cancer Research and Treatment. 188, 2, p. 433-439 7 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
A Phase II Study of the Efficacy and Safety of Chloroquine in Combination With Taxanes in the Treatment of Patients With Advanced or Metastatic Anthracycline-refractory Breast Cancer
Anand, K., Niravath, P., Patel, T., Ensor, J., Rodriguez, A., Boone, T., Wong, S. T. & Chang, J. C., Jun 2021, In: Clinical Breast Cancer. 21, 3, p. 199-204 6 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
A randomized, placebo-controlled phase 2 study of paclitaxel in combination with reparixin compared to paclitaxel alone as front-line therapy for metastatic triple-negative breast cancer (fRida)
for the fRida Trial Investigators, 2021, (Accepted/In press) In: Breast Cancer Research and Treatment.Research output: Contribution to journal › Article › peer-review
Open Access -
Benchmarks for Academic Oncology Faculty
Anthony, L., Atweh, G., Bhatia, R., Carey, L. A., Chang, J. C., Edelman, M. J., Kantoff, P. W., Markham, M. J., Messersmith, W., Nelson, E. L., Oettel, K., O'Regan, R., Verschraegen, C. F. & Vose, J. M., Mar 1 2021, In: JCO oncology practice. 17, 3, p. e440-e444Research output: Contribution to journal › Review article › peer-review
-
Enhancing Inflammation Targeting Using Tunable Leukocyte-Based Biomimetic Nanoparticles
Zinger, A., Sushnitha, M., Naoi, T., Baudo, G., De Rosa, E., Chang, J., Tasciotti, E. & Taraballi, F., Apr 27 2021, In: ACS Nano. 15, 4, p. 6326-6339 14 p.Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations -
Measuring Ovarian Escape in Premenopausal Estrogen Receptor-Positive Breast Cancer Patients on Ovarian Suppression Therapy
Burns, E., Koca, E., Xu, J., McLean, E., Lee, R., Patel, T., Chang, J. & Niravath, P., Jun 2021, In: Oncologist. 26, 6, p. e936-e942Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Sacituzumab govitecan, a Trop-2-directed antibody-drug conjugate, for patients with epithelial cancer: final safety and efficacy results from the phase I/II IMMU-132-01 basket trial
Bardia, A., Messersmith, W. A., Kio, E. A., Berlin, J. D., Vahdat, L., Masters, G. A., Moroose, R., Santin, A. D., Kalinsky, K., Picozzi, V., O'Shaughnessy, J., Gray, J. E., Komiya, T., Lang, J. M., Chang, J. C., Starodub, A., Goldenberg, D. M., Sharkey, R. M., Maliakal, P., Hong, Q. & 3 others, , Jun 2021, In: Annals of Oncology. 32, 6, p. 746-756 11 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Targeting mTOR and DNA repair pathways in residual triple negative breast cancer post neoadjuvant chemotherapy
Anand, K., Patel, T., Niravath, P., Rodriguez, A., Darcourt, J., Belcheva, A., Boone, T., Ensor, J. & Chang, J., Dec 2021, In: Scientific Reports. 11, 1, 82.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
2020
A comprehensive overview of metaplastic breast cancer: clinical features and molecular aberrations
Reddy, T. P., Rosato, R. R., Li, X., Moulder, S., Piwnica-Worms, H. & Chang, J. C., Dec 1 2020, In: Breast Cancer Research. 22, 1, 121.Research output: Contribution to journal › Review article › peer-review
Open Access5 Scopus citations -
A Deep Learning-Based Decision Support Tool for Precision Risk Assessment of Breast Cancer
He, T., Puppala, M., Ezeana, C. F., Huang, Y-S., Chou, P-H., Yu, X., Chen, S., Wang, L., Yin, Z., Danforth, R. L., Ensor, J., Chang, J., Patel, T. & Wong, S. T. C., Jan 2020, In: JCO Clinical Cancer Informatics. 3, p. 1-12 12 p.Research output: Contribution to journal › Article › peer-review
13 Scopus citations -
Antihistamine drug ebastine inhibits cancer growth by targeting polycomb group protein EZH2
Li, Q., Liu, K. Y., Liu, Q., Wang, G., Jiang, W., Meng, Q., Yi, Y., Yang, Y., Wang, R., Zhu, S., Li, C., Wu, L., Zhao, D., Yan, L., Zhang, L., Kim, J. S., Zu, X., Kozielski, A. J., Qian, W., Chang, J. C. & 3 others, , Oct 1 2020, In: Molecular Cancer Therapeutics. 19, 10, p. 2023-2033 11 p.Research output: Contribution to journal › Article › peer-review
4 Scopus citations -
A window-of-opportunity trial of the CXCR1/2 inhibitor reparixin in operable HER-2-negative breast cancer
Goldstein, L. J., Perez, R. P., Yardley, D., Han, L. K., Reuben, J. M., Gao, H., McCanna, S., Butler, B., Ruffini, P. A., Liu, Y., Rosato, R. R. & Chang, J. C., Jan 10 2020, In: Breast Cancer Research. 22, 1, 4.Research output: Contribution to journal › Article › peer-review
19 Scopus citations -
Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015
the Translational Breast Cancer Research Consortium (TBCRC), Jun 1 2020, In: Breast Cancer Research and Treatment. 181, 3, p. 623-633 11 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
Combination PI3K and NOS targeted therapy for metaplastic breast cancer
Reddy, T., Rosato, R., Guzman, L., Qian, W., Zhou, J., Piwnica-Worms, H., Moulder, S. & Chang, J., Oct 2020, In: European Journal of Cancer. 138, p. S49-S50Research output: Contribution to journal › Article › peer-review
Open Access -
Correction to: A window-of-opportunity trial of the CXCR1/2 inhibitor reparixin in operable HER-2-negative breast cancer (Breast Cancer Research (2020) 22: 4 DOI: 10.1186/s13058-019-1243-8)
Goldstein, L. J., Perez, R. P., Yardley, D., Han, L. K., Reuben, J. M., Gao, H., McCanna, S., Butler, B., Ruffini, P. A., Liu, Y., Rosato, R. R. & Chang, J. C., May 20 2020, In: Breast Cancer Research. 22, 1, 52.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Emerging treatment strategies for breast cancer brain metastasis: from translational therapeutics to real-world experience
Ren, D., Cheng, H., Wang, X., Vishnoi, M., Teh, B. S., Rostomily, R., Chang, J. C., Wong, S. T. & Zhao, H., Jun 30 2020, (E-pub ahead of print) In: Therapeutic Advances in Medical Oncology. 12Research output: Contribution to journal › Review article › peer-review
5 Scopus citations -
Erratum: Bromodomain and extraterminal protein inhibition blocks growth of triple-negative breast cancers through the suppression of aurora kinases (J. Biol. Chem. (2016) 291 (23756-23768) DOI: 10.1074/jbc.M116.738666)
Sahni, J. M., Gayle, S. S., Weber Bonk, K. L., Vite, L. C., Yori, J. L., Webb, B., Ramos, E. K., Seachrist, D. D., Landis, M. D., Chang, J. C., Bradner, J. E. & Keri, R. A., Jul 3 2020, In: Journal of Biological Chemistry. 295, 27, p. 9266 1 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Inhibition of EZH2 Catalytic Activity Selectively Targets a Metastatic Subpopulation in Triple-Negative Breast Cancer
Yomtoubian, S., Lee, S. B., Verma, A., Izzo, F., Markowitz, G., Choi, H., Cerchietti, L., Vahdat, L., Brown, K. A., Andreopoulou, E., Elemento, O., Chang, J., Inghirami, G., Gao, D., Ryu, S. & Mittal, V., Jan 21 2020, In: Cell Reports. 30, 3, p. 755-770.e6Research output: Contribution to journal › Article › peer-review
14 Scopus citations -
MEK activation modulates glycolysis and supports suppressive myeloid cells in TNBC
Franklin, D. A., Sharick, J. T., Ericsson-Gonzalez, P. I., Sanchez, V., Dean, P. T., Opalenik, S. R., Cairo, S., Judde, J. G., Lewis, M. T., Chang, J. C., Sanders, M. E., Cook, R. S., Skala, M. C., Bordeaux, J., Orozco Bender, J., Vaupel, C., Geiss, G., Hinerfeld, D. & Balko, J. M., Aug 6 2020, In: JCI insight. 5, 15, e134290.Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
Metastatic triple-negative breast cancer: Established and emerging treatments
Puri, A., Reddy, T. P., Patel, T. A. & Chang, J. C., Jun 23 2020, (E-pub ahead of print) In: Breast Journal. 26, 9, p. 1793-1796 4 p.Research output: Contribution to journal › Article › peer-review
4 Scopus citations -
Simultaneous targeting of HER family pro-survival signaling with Pan-HER antibody mixture is highly effective in TNBC: a preclinical trial with PDXs
Reddy, T. P., Choi, D. S., Anselme, A. C., Qian, W., Chen, W., Lantto, J., Horak, I. D., Kragh, M., Chang, J. C. & Rosato, R. R., May 15 2020, In: Breast cancer research : BCR. 22, 1, p. 48 1 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
2019
A combinatorial biomarker predicts pathologic complete response to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2+ breast cancer
Veeraraghavan, J., De Angelis, C., Mao, R., Wang, T., Herrera, S., Pavlick, A. C., Contreras, A., Nuciforo, P., Mayer, I. A., Forero, A., Nanda, R., Goetz, M. P., Chang, J. C., Wolff, A. C., Krop, I. E., Fuqua, S. A. W., Prat, A., Hilsenbeck, S. G., Weigelt, B., Reis-Filho, J. S. & 4 others, , Jun 1 2019, In: Annals of Oncology. 30, 6, p. 927-933 7 p., mdz076.Research output: Contribution to journal › Article › peer-review
22 Scopus citations -
A randomized, controlled phase II trial of neoadjuvant ado-trastuzumab emtansine, lapatinib, and nab-paclitaxel versus trastuzumab, pertuzumab, and paclitaxel in HER2-positive breast cancer (TEAL study)
Patel, T., Ensor, Jr., J. E., Creamer, S. L., Boone, T., Rodriguez, A. A., Niravath, P. A., Darcourt, J., Meisel, J. L., Li, X., Zhao, J., Kuhn, J. G., Rosato, R. R., Qian, W., Belcheva, A., Schwartz, M. R., Kaklamani, V. G. & Chang, J. C., Sep 2 2019, In: Breast Cancer Research. 21, 1, 100.Research output: Contribution to journal › Article › peer-review
8 Scopus citations -
Autophagy inhibition elicits emergence from metastatic dormancy by inducing and stabilizing Pfkfb3 expression
La Belle Flynn, A., Calhoun, B. C., Sharma, A., Chang, J. C., Almasan, A. & Schiemann, W. P., Aug 14 2019, In: Nature Communications. 10, 1, 3668.Research output: Contribution to journal › Article › peer-review
36 Scopus citations -
Cancer therapeutic targeting using mutant–p53-specific siRNAs
Ubby, I., Krueger, C., Rosato, R., Qian, W., Chang, J. & Sabapathy, K., May 2 2019, In: Oncogene. 38, 18, p. 3415-3427 13 p.Research output: Contribution to journal › Article › peer-review
10 Scopus citations -
Detection of breast cancer stem cell gene mutations in circulating free DNA during the evolution of metastases
Liu, Z. B., Ezzedine, N. E., Eterovic, A. K., Ensor, Jr., J. E., Huang, H. J., Albanell, J., Choi, D. S., Lluch, A., Liu, Y., Rojo, F., Wong, H., Martínez-Dueñas, E., Guerrero-Zotano, Á., Shao, Z. M., Darcourt, J., Mills, G. B., Dave, B. & Chang, J. C., Nov 1 2019, In: Breast Cancer Research and Treatment. 178, 2, p. 251-261 11 p.Research output: Contribution to journal › Article › peer-review
5 Scopus citations -
Developing a model to predict accrual to cancer clinical trials: Data from an NCI designated cancer center
Iruku, P., Goros, M., Gelfond, J., Chang, J., Padalecki, S., Mesa, R. & Kaklamani, V. G., Sep 2019, In: Contemporary Clinical Trials Communications. 15, 100421.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Erratum: Triple-negative breast cancers with amplication of JAK2 at the 9p24 locus demonstrate JAK2-specic dependence (Science Translational Medicine (2019) 11, 476, (eaaw6162), 10.1126/scitranslmed.aaw6162)
Balko, J. M., Schwarz, L. J., Luo, N., Estrada, M. V., Giltnane, J. M., Dávila-González, D., Wang, K., Sánchez, V., Dean, P. T., Combs, S. E., Hicks, D., Pinto, J. A., Landis, M. D., Doimi, F. D., Yelensky, R., Miller, V. A., Stephens, P. J., Rimm, D. L., Gómez, H., Chang, J. C. & 3 others, , Jan 23 2019, In: Science translational medicine. 11, 476, eaaw6162.Research output: Contribution to journal › Review article › peer-review
-
Hydroxytyrosol inhibits cancer stem cells and the metastatic capacity of triple-negative breast cancer cell lines by the simultaneous targeting of epithelial-to-mesenchymal transition, Wnt/β-catenin and TGFβ signaling pathways
Cruz-Lozano, M., González-González, A., Marchal, J. A., Muñoz-Muela, E., Molina, M. P., Cara, F. E., Brown, A. M., García-Rivas, G., Hernández-Brenes, C., Lorente, J. A., Sanchez-Rovira, P., Chang, J. C. & Granados-Principal, S., Dec 1 2019, In: European Journal of Nutrition. 58, 8, p. 3207-3219 13 p.Research output: Contribution to journal › Article › peer-review
18 Scopus citations -
Prognosis of lymphotropic invasive micropapillary breast carcinoma analyzed by using data from the National Cancer Database
Lewis, G. D., Xing, Y., Haque, W. M., Patel, T., Schwartz, M., Chen, A., Farach, A. M., Hatch, S. S., Butler, E. B., Chang, J. C. & Teh, B. S., Oct 21 2019, In: Cancer Communications. 39, 1, 60.Research output: Contribution to journal › Article › peer-review
6 Scopus citations -
The impact of molecular status on survival outcomes for invasive micropapillary carcinoma of the breast
Lewis, G. D., Xing, Y., Haque, W. M., Patel, T., Schwartz, M. R., Chen, A. C., Farach, A. M., Hatch, S. S., Butler, E. B., Chang, J. C. & Teh, B. S., Nov 1 2019, In: Breast Journal. 25, 6, p. 1171-1176 6 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
2018
A Behavior-Modification, Clinical-Grade Mobile Application to Improve Breast Cancer Survivors' Accountability and Health Outcomes
Stubbins, R., He, T., Yu, X., Puppala, M., Ezeana, C. F., Chen, S., Valdivia y Alvarado, M., Ensor, J., Rodriguez, A., Niravath, P., Chang, J., Wong, S. T. C. & Patel, T., Nov 1 2018, In: JCO Clinical Cancer Informatics. 2, p. 1-11 11 p.Research output: Contribution to journal › Article › peer-review
6 Scopus citations -
Activating Transcription Factor 4 Modulates TGFβ-Induced Aggressiveness in Triple-Negative Breast Cancer via SMAD2/3/4 and mTORC2 Signaling
González-González, A., Muñoz-Muela, E., Marchal, J. A., Cara, F. E., Molina, M. P., Cruz-Lozano, M., Jiménez, G., Verma, A., Ramírez, A., Qian, W., Chen, W., Kozielski, A. J., Elemento, O., Martín-Salvago, M. D., Luque, R. J., Rosa-Garrido, C., Landeira, D., Quintana-Romero, M., Rosato, R. R., García, M. A. & 9 others, , Nov 15 2018, In: Clinical Cancer Research. 24, 22, p. 5697-5709 13 p.Research output: Contribution to journal › Article › peer-review
15 Scopus citations -
Evaluation of anti-PD-1-based therapy against triple-negative breast cancer patient-derived xenograft tumors engrafted in humanized mouse models
Rosato, R. R., Dávila-González, D., Choi, D. S., Qian, W., Chen, W., Kozielski, A. J., Wong, H., Dave, B. & Chang, J. C., Sep 5 2018, In: Breast Cancer Research. 20, 1, 108.Research output: Contribution to journal › Article › peer-review
38 Scopus citations -
Low PETN levels and PIK3CA mutations predict resistance to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2 over-expressing breast cancer
Rimawi, M. F., de Angelis, C., Contreras, A., Pareja, F., Geyer, F. C., Burke, K. A., Herrera, S., Wang, T., Mayer, I. A., Forero, A., Nanda, R., Goetz, M. P., Chang, J. C., Krop, I. E., Wolff, A. C., Pavlick, A. C., Fuqua, S. A. W., Gutierrez, C., Hilsenbeck, S. G., Li, M. M. & 4 others, , Nov 7 2018, In: Breast Cancer Research and Treatment. 167, 3, p. 731-740 10 p.Research output: Contribution to journal › Article › peer-review
42 Scopus citations -
Pharmacological inhibition of NOS activates ASK1/JNK pathway augmenting docetaxel-mediated apoptosis in triple-negative breast cancer
Davila-Gonz alez, D., Choi, D. S., Rosato, R. R., Granados-Principal, S. M., Kuhn, J. G., Li, W. F., Qian, W., Chen, W., Kozielski, A. J., Wong, H., Dave, B. & Chang, J. C., Mar 1 2018, In: Clinical Cancer Research. 24, 5, p. 1152-1162 11 p.Research output: Contribution to journal › Article › peer-review
38 Scopus citations -
The ERβ4 variant induces transformation of the normal breast mammary epithelial cell line MCF-10A; the ERβ variants ERβ2 and ERβ5 increase aggressiveness of TNBC by regulation of hypoxic signaling
Faria, M., Karami, S., Granados-Principal, S., Dey, P., Verma, A., Choi, D. S., Elemento, O., Bawa-Khalfe, T., Chang, J. C., Strom, A. M. & Gustafsson, J. Å., 2018, In: Oncotarget. 9, 15, p. 12201-12211 11 p.Research output: Contribution to journal › Article › peer-review
7 Scopus citations -
Treatment Outcomes and Prognostic Factors in Male Patients With Stage IV Breast Cancer: A Population-based Study
Chen, W., Huang, Y., Lewis, G. D., Szeja, S. S., Hatch, S. S., Farach, A., Miltenburg, D., Butler, E. B., Chang, J. C. & Teh, B. S., Feb 2018, In: Clinical Breast Cancer. 18, 1, p. e97-e105Research output: Contribution to journal › Article › peer-review
6 Scopus citations -
2017
A randomized phase II neoadjuvant study of cisplatin, paclitaxel with or without everolimus in patients with stage II/III triple-negative breast cancer (TNBC): Responses and long-term outcome correlated with increased frequency of DNA damage response gene mutations, TNBC subtype, AR status, and Ki67
Jovanovic, B., Mayer, I. A., Mayer, E. L., Abramson, V. G., Bardia, A., Sanders, M. E., Kuba, M. G., Estrada, M. V., Beeler, J. S., Shaver, T. M., Johnson, K. C., Sanchez, V., Rosenbluth, J. M., Dillon, P. M., Forero-Torres, A., Chang, J. C., Meszoely, I. M., Grau, A. M., Lehmann, B. D., Shyr, Y. & 4 others, , Aug 1 2017, In: Clinical Cancer Research. 23, 15, p. 4035-4045 11 p.Research output: Contribution to journal › Article › peer-review
57 Scopus citations -
Deep learning analytics for diagnostic support of breast cancer disease management
He, T., Puppala, M., Ogunti, R., Mancuso, J. J., Yu, X., Chen, S., Chang, J. C., Patel, T. A. & Wong, S. T. C., Apr 11 2017, 2017 IEEE EMBS International Conference on Biomedical and Health Informatics, BHI 2017. Institute of Electrical and Electronics Engineers Inc., p. 365-368 4 p. 7897281. (2017 IEEE EMBS International Conference on Biomedical and Health Informatics, BHI 2017).Research output: Chapter in Book/Report/Conference proceeding › Conference contribution
9 Scopus citations -
HN1L Promotes Triple-Negative Breast Cancer Stem Cells through LEPR-STAT3 Pathway
Liu, Y., Choi, D. S., Sheng, J., Ensor, J. E., Liang, D. H., Rodriguez-Aguayo, C., Polley, A., Benz, S., Elemento, O., Verma, A., Cong, Y., Wong, H., Qian, W., Li, Z., Granados-Principal, S., Lopez-Berestein, G., Landis, M. D., Rosato, R. R., Dave, B., Wong, S. & 3 others, , Dec 8 2017, (E-pub ahead of print) In: Stem Cell Reports.Research output: Contribution to journal › Article › peer-review
26 Scopus citations -
Molecular characterization of breast cancer CTCs associated with brain metastasis
Boral, D., Vishnoi, M., Liu, H. N., Yin, W., Sprouse, M. L., Scamardo, A., Hong, D. S., Tan, T. Z., Thiery, J. P., Chang, J. C. & Marchetti, D., Dec 1 2017, In: Nature Communications. 8, 1, 31 p., 196.Research output: Contribution to journal › Article › peer-review
82 Scopus citations -
Mutant p53 dictates the oncogenic activity of c-Abl in triple-negative breast cancers
Morrison, C. D., Chang, J. C., Keri, R. A. & Schiemann, W. P., Jun 29 2017, In: Cell death & disease. 8, 6, p. e2899Research output: Contribution to journal › Article › peer-review
7 Scopus citations -
NO and COX2: Dual targeting for aggressive cancers
Davila-Gonzalez, D., Chang, J. C. & Billiar, T. R., Dec 26 2017, In: Proceedings of the National Academy of Sciences of the United States of America. 114, 52, p. 13591-13593 3 p.Research output: Contribution to journal › Comment/debate › peer-review
13 Scopus citations -
Role of RPL39 in Metaplastic Breast Cancer
Dave, B., Gonzalez, D. D., Liu, Z. B., Li, X., Wong, H., Granados, S., Ezzedine, N. E., Sieglaff, D. H., Ensor, J. E., Miller, K. D., Radovich, M., KarinaEtrovic, A., Gross, S. S., Elemento, O., Mills, G. B., Gilcrease, M. Z. & Chang, J. C., Jun 2017, In: Journal of the National Cancer Institute. 109, 6Research output: Contribution to journal › Article › peer-review
36 Scopus citations -
The lncRNA BORG Drives Breast Cancer Metastasis and Disease Recurrence
Gooding, A. J., Zhang, B., Jahanbani, F. K., Gilmore, H. L., Chang, J. C., Valadkhan, S. & Schiemann, W. P., Dec 1 2017, In: Scientific Reports. 7, 1, 12698.Research output: Contribution to journal › Article › peer-review
49 Scopus citations -
2016
A comparison between DASL and Affymetrix on probing the whole-transcriptome
Jeong, J., Audet, R., Chang, J., Wong, H., Willis, S., Young, B., Edgerton, S., Thor, A., Sledge, G., Duchnowska, R., Jassem, J., Adamowicz, K., Leyland-Jones, B. & Shen, C., Mar 1 2016, In: Journal of the Korean Statistical Society. 45, 1, p. 149-155 7 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Analysis of phosphatases in ER-negative breast cancers identifies DUSP4 as a critical regulator of growth and invasion
Mazumdar, A., Poage, G. M., Shepherd, J., Tsimelzon, A., Hartman, Z. C., Den Hollander, P., Hill, J., Zhang, Y., Chang, J. C., Hilsenbeck, S. G., Fuqua, S., Kent Osborne, C., Mills, G. B. & Brown, P. H., Aug 1 2016, In: Breast Cancer Research and Treatment. 158, 3, p. 441-454 14 p.Research output: Contribution to journal › Article › peer-review
17 Scopus citations